AU2984700A - Injectable collagen-based delivery system for bone morphogenic proteins - Google Patents

Injectable collagen-based delivery system for bone morphogenic proteins

Info

Publication number
AU2984700A
AU2984700A AU29847/00A AU2984700A AU2984700A AU 2984700 A AU2984700 A AU 2984700A AU 29847/00 A AU29847/00 A AU 29847/00A AU 2984700 A AU2984700 A AU 2984700A AU 2984700 A AU2984700 A AU 2984700A
Authority
AU
Australia
Prior art keywords
delivery system
bone morphogenic
based delivery
morphogenic proteins
injectable collagen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29847/00A
Inventor
Dale P. Devore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Collagenesis Inc
Original Assignee
Collagenesis Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Collagenesis Inc filed Critical Collagenesis Inc
Publication of AU2984700A publication Critical patent/AU2984700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
AU29847/00A 1999-02-12 2000-02-07 Injectable collagen-based delivery system for bone morphogenic proteins Abandoned AU2984700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11993999P 1999-02-12 1999-02-12
US60119939 1999-02-12
PCT/US2000/003151 WO2000047114A1 (en) 1999-02-12 2000-02-07 Injectable collagen-based delivery system for bone morphogenic proteins

Publications (1)

Publication Number Publication Date
AU2984700A true AU2984700A (en) 2000-08-29

Family

ID=22387302

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29847/00A Abandoned AU2984700A (en) 1999-02-12 2000-02-07 Injectable collagen-based delivery system for bone morphogenic proteins

Country Status (2)

Country Link
AU (1) AU2984700A (en)
WO (1) WO2000047114A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020114795A1 (en) * 2000-12-22 2002-08-22 Thorne Kevin J. Composition and process for bone growth and repair
JP4451658B2 (en) * 2001-10-18 2010-04-14 ライフセル コーポレーション Tissue and organ remodeling
IL149562A0 (en) 2002-05-09 2002-11-10 Prochon Ltd Fgf variants and methods for use thereof
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
CN1279973C (en) * 2004-07-22 2006-10-18 徐放 Injected gel type bone repairing biological active material and its preparing method
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
US8921109B2 (en) 2005-09-19 2014-12-30 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US8048857B2 (en) 2006-12-19 2011-11-01 Warsaw Orthopedic, Inc. Flowable carrier compositions and methods of use
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
US20090054984A1 (en) 2007-08-20 2009-02-26 Histogenics Corporation Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects
US8685107B2 (en) 2007-07-03 2014-04-01 Histogenics Corporation Double-structured tissue implant and a method for preparation and use thereof
WO2009111069A1 (en) 2008-03-05 2009-09-11 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
US8469779B1 (en) 2009-01-02 2013-06-25 Lifecell Corporation Method for debristling animal skin
EP2696908B1 (en) 2011-04-14 2015-03-11 Lifecell Corporation Regenerative materials
KR101274930B1 (en) * 2011-06-03 2013-06-17 전남대학교산학협력단 Bone forming peptide 4 for promoting osteogenesis or vascularization and use thereof
US9089523B2 (en) 2011-07-28 2015-07-28 Lifecell Corporation Natural tissue scaffolds as tissue fillers
EP2793964B1 (en) 2011-12-20 2019-03-20 LifeCell Corporation Sheet tissue products
DK3501558T3 (en) 2011-12-20 2021-03-01 Lifecell Corp LIQUID TISSUE PRODUCTS
US9271821B2 (en) 2012-01-24 2016-03-01 Lifecell Corporation Elongated tissue matrices
BR112014026090A8 (en) 2012-04-24 2019-08-27 Lifecell Corp flowable tissue matrix composition
WO2013162997A1 (en) 2012-04-24 2013-10-31 Lifecell Corporation Functionalized tissue matrices
WO2014011402A1 (en) 2012-07-13 2014-01-16 Lifecell Corporation Methods for improved treatment of adipose tissue
AU2013323747B2 (en) 2012-09-26 2017-02-02 Lifecell Corporation Processed adipose tissue
EA201591621A1 (en) 2013-03-04 2015-12-30 ДЕРМЕЛЛ, ЭлЭлСи ди/би/эй ИТЕРНОДЖЕН, ЭлЭлСи SUITABLE FOR INJECTION ABLE FOR POLYMERIZATION IN SITU COLLAGENIC COMPOSITION
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
US10821205B2 (en) 2017-10-18 2020-11-03 Lifecell Corporation Adipose tissue products and methods of production
US11123375B2 (en) 2017-10-18 2021-09-21 Lifecell Corporation Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
EP3697462B1 (en) 2017-10-19 2023-07-12 LifeCell Corporation Flowable acellular tissue matrix products and methods of production
WO2020243497A1 (en) 2019-05-30 2020-12-03 Lifecell Corporation Biologic breast implant

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0662679B2 (en) * 1985-06-21 1994-08-17 新田ゼラチン株式会社 Tissue-friendly collagen and its manufacturing method
US5475052A (en) * 1988-11-21 1995-12-12 Collagen Corporation Collagen-synthetic polymer matrices prepared using a multiple step reaction
US5208219A (en) * 1991-02-14 1993-05-04 Celtrix Pharmaceuticals Inc. Method for inducing bone growth
US5492135A (en) * 1992-09-09 1996-02-20 Devore; Dale P. Collagen modulators for use in photoablation excimer laser keratectomy
US6039762A (en) * 1995-06-07 2000-03-21 Sdgi Holdings, Inc. Reinforced bone graft substitutes
US5674292A (en) * 1995-06-07 1997-10-07 Stryker Corporation Terminally sterilized osteogenic devices and preparation thereof
US6007833A (en) * 1998-03-19 1999-12-28 Surmodics, Inc. Crosslinkable macromers bearing initiator groups

Also Published As

Publication number Publication date
WO2000047114A1 (en) 2000-08-17

Similar Documents

Publication Publication Date Title
AU2984700A (en) Injectable collagen-based delivery system for bone morphogenic proteins
AU6956398A (en) Implant delivery system
AU7420000A (en) Fixation system for bones
AU6168699A (en) Non-compliant system for delivery of implant material
AU7518800A (en) Fixing system for bones
AU5726900A (en) Femoral intramedullary rod system
AU3385199A (en) Stent delivery system
AU1618800A (en) Microporous drug delivery system
AU4989399A (en) Bone morphogenic protein
IL117702A0 (en) Drug for hyperlipoproteinemia
AU7711098A (en) Drug delivery system
AU7201998A (en) Drug delivery system
AU4905700A (en) Neural transplantation delivery system
AU8636798A (en) Pharmaceutical compounds isolated from aristolochia taliscana
AU5744200A (en) Human transport proteins
AU4073600A (en) Bone morphogenic proteins
AU7937500A (en) Pharmaceutical composition containing midazolam
AU2420997A (en) Oligopeptides for drug delivery
AU2009501A (en) Conveyor system
AU1671997A (en) Drug delivery system using galactoxyloglucan
AU3473800A (en) Conotoxin peptides
AU3455000A (en) Composition for decomposing protein
AU4214800A (en) Vesicle associated proteins
AU1157201A (en) Conveyor system
AU1174301A (en) Sequential imaging system

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase